nodes	percent_of_prediction	percent_of_DWPC	metapath
Furazolidone—MAOB—nerve—amyotrophic lateral sclerosis	0.119	0.134	CbGeAlD
Furazolidone—MAOA—nerve—amyotrophic lateral sclerosis	0.101	0.114	CbGeAlD
Furazolidone—MAOB—hindbrain—amyotrophic lateral sclerosis	0.0889	0.1	CbGeAlD
Furazolidone—MAOA—hindbrain—amyotrophic lateral sclerosis	0.0758	0.0854	CbGeAlD
Furazolidone—MAOB—embryo—amyotrophic lateral sclerosis	0.0556	0.0626	CbGeAlD
Furazolidone—MAOB—brainstem—amyotrophic lateral sclerosis	0.0509	0.0574	CbGeAlD
Furazolidone—MAOA—embryo—amyotrophic lateral sclerosis	0.0474	0.0534	CbGeAlD
Furazolidone—MAOA—brainstem—amyotrophic lateral sclerosis	0.0435	0.0489	CbGeAlD
Furazolidone—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.0355	0.04	CbGeAlD
Furazolidone—MAOB—spinal cord—amyotrophic lateral sclerosis	0.0317	0.0357	CbGeAlD
Furazolidone—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.0303	0.0341	CbGeAlD
Furazolidone—MAOA—spinal cord—amyotrophic lateral sclerosis	0.027	0.0304	CbGeAlD
Furazolidone—MAOB—nervous system—amyotrophic lateral sclerosis	0.0267	0.0301	CbGeAlD
Furazolidone—MAOB—central nervous system—amyotrophic lateral sclerosis	0.0257	0.0289	CbGeAlD
Furazolidone—MAOB—cerebellum—amyotrophic lateral sclerosis	0.0251	0.0283	CbGeAlD
Furazolidone—MAOA—nervous system—amyotrophic lateral sclerosis	0.0228	0.0256	CbGeAlD
Furazolidone—MAOA—central nervous system—amyotrophic lateral sclerosis	0.0219	0.0247	CbGeAlD
Furazolidone—MAOA—cerebellum—amyotrophic lateral sclerosis	0.0214	0.0241	CbGeAlD
Furazolidone—MAOB—brain—amyotrophic lateral sclerosis	0.0204	0.023	CbGeAlD
Furazolidone—MAOA—brain—amyotrophic lateral sclerosis	0.0174	0.0196	CbGeAlD
Furazolidone—MAOA—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.0118	0.105	CbGpPWpGaD
Furazolidone—MAOB—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.0116	0.104	CbGpPWpGaD
Furazolidone—MAOA—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0108	0.0965	CbGpPWpGaD
Furazolidone—MAOA—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.00824	0.0737	CbGpPWpGaD
Furazolidone—MAOA—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00728	0.065	CbGpPWpGaD
Furazolidone—MAOA—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00517	0.0462	CbGpPWpGaD
Furazolidone—MAOA—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00461	0.0412	CbGpPWpGaD
Furazolidone—MAOA—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.00373	0.0333	CbGpPWpGaD
Furazolidone—MAOA—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00283	0.0253	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00281	0.0251	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00196	0.0175	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0162	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00181	0.0162	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00181	0.0162	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00181	0.0161	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00175	0.0156	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0016	0.0143	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0015	0.0134	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00148	0.0133	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00148	0.0133	CbGpPWpGaD
Furazolidone—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00143	0.0128	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00138	0.0124	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00134	0.0119	CbGpPWpGaD
Furazolidone—MAOA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00132	0.0118	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00122	0.0109	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00114	0.0102	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00114	0.0102	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0011	0.00982	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0011	0.00982	CbGpPWpGaD
Furazolidone—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00101	0.00906	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00101	0.00898	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000937	0.00837	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000934	0.00835	CbGpPWpGaD
Furazolidone—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0009	0.00804	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000879	0.00785	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000795	0.0071	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00069	0.00616	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00069	0.00616	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000631	0.00564	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000602	0.00538	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000586	0.00524	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000556	0.00497	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000551	0.00493	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000499	0.00445	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000468	0.00418	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000456	0.00408	CbGpPWpGaD
Furazolidone—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000397	0.00355	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000378	0.00338	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000349	0.00312	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000286	0.00256	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000245	0.00219	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000225	0.00201	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	0.000185	0.00166	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000154	0.00138	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000141	0.00126	CbGpPWpGaD
Furazolidone—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000127	0.00114	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	0.000116	0.00104	CbGpPWpGaD
Furazolidone—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.97e-05	0.000712	CbGpPWpGaD
